$AVO Cashflow Statement | Understand Stock

$AVO

$11.61 -$0.16 (1.36%) Close

$AVO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Oct 31, 2025	FY2024 12 months to Oct 31, 2024	FY2023 12 months to Oct 31, 2023	FY2022 12 months to Oct 31, 2022	FY2021 12 months to Oct 31, 2021
Operating Activities
Net income (loss)
Adjustments to reconcile net income (loss) to net cash provided by operating activities
(Benefit) provision for losses on accounts receivable
Depreciation and amortization
Amortization of debt issuance costs
Equity method income
Noncash lease expense
Stock-based compensation
Dividends received from equity method investees
Losses on asset impairment, disposals and sales, net of insurance recoveries
Gains on settlement of asset retirement obligations
Deferred income taxes
Goodwill impairment
Remeasurement gain on business combination with Moruga
Impairment on equity method investment
Unrealized losses (gains) on foreign currency transactions
Unrealized loss on derivative financial instruments
Other

Effect on cash of changes in operating assets and liabilities:
Trade accounts receivable
Grower fruit advances
Other receivables
Inventory
Prepaid expenses and other current assets
Income taxes receivable
Other assets
Accounts payable and accrued expenses
Income taxes payable
Grower payables
Operating lease liabilities
Other long-term liabilities
Net cash provided by operating activities
Investing Activities
Purchases of property, plant and equipment
Proceeds from sale of property, plant and equipment
Insurance proceeds for the replacement of property, plant and equipment
Cash acquired in consolidation of Moruga
Investment in equity method investees
Purchase of other investment
Loans to equity method investees
Loan repayments from equity method investees
Other
Net cash used in investing activities
Financing Activities
Borrowings on revolving credit facility
Payments on revolving credit facility
Proceeds from short-term borrowings
Repayment of short-term borrowings
Principal payments on long-term debt obligations
Principal payments on finance lease obligations
Proceeds from loan from noncontrolling interest holder
Principal payments on loans due to noncontrolling interest holder
Payments to noncontrolling interest holder for long-term supply financing
Payments for long-term supplier financing
Payment for debt extinguishment costs
Repurchase and retirement of common stock
Proceeds from issuance of common stock in public offering, net of issuance costs
Dividends paid
Taxes paid related to shares withheld from the settlement of equity awards
Exercise of stock options
Repayment of stock option notes receivable
Payment of debt issuance, restructuring or extinguishment fees
Equity contributions from noncontrolling interest holders
Net cash (used in) provided by financing activities

Effect of exchange rate changes on cash
Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash, beginning of period
Cash, cash equivalents and restricted cash, end of period
Cash paid during the year for:
Interest
Income taxes
Non-cash investing and financing activities:
Property, plant and equipment included in liabilities
Advances for property, plant and equipment included in assets
Finance leases of property, plant and equipment
Common stock issued in lieu of compensation 7,921 shares issued in 2020)
Purchases from noncontrolling interest holder made with payment terms greater than 90 days
Purchases from suppliers with payment terms greater than 90 days
Elimination of loan receivable from Moruga upon consolidation (Note 3)

Summary of cash, cash equivalents and restricted cash reported within the consolidated balance sheets:
Cash and cash equivalents
Restricted cash
Restricted cash included in other assets

Comments